Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
The Alathur facility specializes in the production of Cephalosporin antibiotics
Revenue up 11% to Rs 5,768 crore as compared to Rs 5,197 crore
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
The biosimilar Ustekinumab has been developed and manufactured by the company
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Subscribe To Our Newsletter & Stay Updated
